These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7626324)

  • 1. Similarities and differences between the effects of ipriflavone and vitamin K on bone resorption and formation in vitro.
    Notoya K; Yoshida K; Shirakawa Y; Taketomi S; Tsuda M
    Bone; 1995 Apr; 16(4 Suppl):349S-353S. PubMed ID: 7626324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibitory effect of vitamin K2 (menatetrenone) on bone resorption may be related to its side chain.
    Hara K; Akiyama Y; Nakamura T; Murota S; Morita I
    Bone; 1995 Feb; 16(2):179-84. PubMed ID: 7756045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of ipriflavone on osteoclast-mediated bone resorption and new osteoclast formation in long-term cultures of mouse unfractionated bone cells.
    Notoya K; Yoshida K; Taketomi S; Yamazaki I; Kumegawa M
    Calcif Tissue Int; 1993 Sep; 53(3):206-9. PubMed ID: 8242474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ipriflavone inhibits murine osteoclast formation in vitro.
    Morita I; Sakaguchi K; Kurachi T; Murota S
    Calcif Tissue Int; 1992; 51 Suppl 1():S7-10. PubMed ID: 1422984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of ipriflavone on expression of markers characteristic of the osteoblast phenotype in rat bone marrow stromal cell culture.
    Notoya K; Yoshida K; Tsukuda R; Taketomi S
    J Bone Miner Res; 1994 Mar; 9(3):395-400. PubMed ID: 8191934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of ipriflavone on pit formation in mouse unfractionated bone cells.
    Notoya K; Yoshida K; Taketomi S; Yamazaki I; Kumegawa M
    Calcif Tissue Int; 1992; 51 Suppl 1():S3-6. PubMed ID: 1422982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in femoral bone mass by ipriflavone alone and in combination with 1 alpha-hydroxyvitamin D3 in growing rats with skeletal unloading.
    Notoya K; Yoshida K; Tsukuda R; Taketomi S; Tsuda M
    Calcif Tissue Int; 1996 Feb; 58(2):88-94. PubMed ID: 8998683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histochemical and fine structural study of bone of ipriflavone-treated rats.
    Ozawa H; Nakamura H; Irie K; Irie M
    Calcif Tissue Int; 1992; 51 Suppl 1():S21-6. PubMed ID: 1422980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Menatetrenone (vitamin K2) acts directly on circulating human osteoclast precursors.
    Taira H; Fujikawa Y; Kudo O; Itonaga I; Torisu T
    Calcif Tissue Int; 2003 Jul; 73(1):78-85. PubMed ID: 14506958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin K2 inhibits osteoclastic bone resorption by inducing osteoclast apoptosis.
    Kameda T; Miyazawa K; Mori Y; Yuasa T; Shiokawa M; Nakamaru Y; Mano H; Hakeda Y; Kameda A; Kumegawa M
    Biochem Biophys Res Commun; 1996 Mar; 220(3):515-9. PubMed ID: 8607797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytological and ultrastructural investigation on osteoblastic and preosteoclastic cells grown in vitro in the presence of ipriflavone: preliminary results.
    Bonucci E; Silvestrini G; Ballanti P; Masi L; Franchi A; Bufalino L; Brandi ML
    Bone Miner; 1992 Oct; 19 Suppl 1():S15-25. PubMed ID: 1422316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel ipriflavone receptors coupled to calcium influx regulate osteoclast differentiation and function.
    Miyauchi A; Notoya K; Taketomi S; Takagi Y; Fujii Y; Jinnai K; Takahashi K; Chihara K; Fujita T
    Endocrinology; 1996 Aug; 137(8):3544-50. PubMed ID: 8754785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of vitamin K2 (menatetrenone) on osteoclast-like cell formation in mouse bone marrow cultures.
    Akiyama Y; Hara K; Tajima T; Murota S; Morita I
    Eur J Pharmacol; 1994 Sep; 263(1-2):181-5. PubMed ID: 7821350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin K promotes mineralization, osteoblast-to-osteocyte transition, and an anticatabolic phenotype by {gamma}-carboxylation-dependent and -independent mechanisms.
    Atkins GJ; Welldon KJ; Wijenayaka AR; Bonewald LF; Findlay DM
    Am J Physiol Cell Physiol; 2009 Dec; 297(6):C1358-67. PubMed ID: 19675304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ipriflavone inhibits osteolytic bone metastasis of human breast cancer cells in a nude mouse model.
    Iwasaki T; Mukai M; Tsujimura T; Tatsuta M; Nakamura H; Terada N; Akedo H
    Int J Cancer; 2002 Aug; 100(4):381-7. PubMed ID: 12115517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin K stimulates osteoblastogenesis and inhibits osteoclastogenesis in human bone marrow cell culture.
    Koshihara Y; Hoshi K; Okawara R; Ishibashi H; Yamamoto S
    J Endocrinol; 2003 Mar; 176(3):339-48. PubMed ID: 12630919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced glycation end products enhance osteoclast-induced bone resorption in cultured mouse unfractionated bone cells and in rats implanted subcutaneously with devitalized bone particles.
    Miyata T; Notoya K; Yoshida K; Horie K; Maeda K; Kurokawa K; Taketomi S
    J Am Soc Nephrol; 1997 Feb; 8(2):260-70. PubMed ID: 9048345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of human osteoblast differentiation and function by ipriflavone and its metabolites.
    Cheng SL; Zhang SF; Nelson TL; Warlow PM; Civitelli R
    Calcif Tissue Int; 1994 Nov; 55(5):356-62. PubMed ID: 7866917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of retinoic acid on bone formation and resorption in cultured mouse calvaria.
    Togari A; Kondo M; Arai M; Matsumoto S
    Gen Pharmacol; 1991; 22(2):287-92. PubMed ID: 2055423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ipriflavone and its metabolites on a clonal osteoblastic cell line.
    Benvenuti S; Tanini A; Frediani U; Bianchi S; Masi L; Casano R; Bufalino L; Serio M; Brandi ML
    J Bone Miner Res; 1991 Sep; 6(9):987-96. PubMed ID: 1665005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.